Is a
Patent attributes
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
June 29, 2021
Patent Application Number
16541743
Date Filed
August 15, 2019
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are compositions comprising one or more antibodies that specifically bind active plasma kallikrein (e.g., human plasma kallikrein) and methods of using such compositions for the treatment of retinal diseases, such as diabetic macular edema.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
